Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 343 followers
Latest posts
Last updated about 7 hours ago
Boston Scientific cyberattack likely to have ‘material impact’ on financial results
about 7 hours ago
The recent cyberattack on Boston Scientific is looking more serious than the...
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
about 7 hours ago
With a detailed data drop that AstraZeneca’s R&D chief describes as an...
Guardant wins FDA nod for diagnostic guiding use of AstraZeneca’s Etcamah
about 8 hours ago
Hot on the heels of the approval for AstraZeneca’s breast cancer drug...
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
about 8 hours ago
In a rare divergence from its own expert panel, the FDA has...
Spyre's 3-pronged IBD strategy on track as IL-23 antibody rounds off trio of phase 2 wins
about 8 hours ago
Spyre's three-pronged approach to inflammatory bowel disease continues to pay off, with...
Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability
about 9 hours ago
Inhibrx Biosciences’ CEO has argued that the 9.6 months of progression-free survival...
Pharvaris' latest phase 3 win builds case for HAE drug with FDA verdict pending
about 9 hours ago
Pharvaris’ deucrictibant has tasted success in a second phase 3 study, strengthening...
Building the Data Foundation for AI-Driven Clinical Development
about 9 hours ago
H1 is transforming clinical development with connected intelligence that improves study design...
Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint
about 10 hours ago
A pivotal trial of Bristol Myers Squibb’s GPRC5D-directed CAR-T cell therapy has...
Boston Scientific recalls spinal cord implant in wake of more than 1k serious injuries
about 11 hours ago
Boston Scientific has issued another recall, this time for its spinal cord...
BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancer
about 12 hours ago
A startup spawned from Seattle Children’s Hospital has raised a $116 million...
Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win
about 12 hours ago
Roivant’s $14 million bet on a pulmonary hypertension drug from Bayer appears...